Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $80M Series A (Mar 2026) co-led by Spark Capital and Transformation Capital. 2M+ patients/year. Partners with 50% of top 20 US health systems. McKesson Ventures strategic investor.
Latent Health is a medication access and prior authorization automation platform that uses its Clinical Reasoning Engine to ingest EHR data, interpret drug approval criteria, and automate the full medication access workflow end-to-end. The company raised $80 million in Series A financing in March 2026 co-led by Spark Capital and Transformation Capital, with McKesson Ventures, General Catalyst, and Y Combinator as co-investors. The platform serves 2 million+ patients annually and is partnered with 50% of the top 20 US health systems.
Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.